A Closer Look at America's Struggle with Alcohol Abuse
STAT highlights the ongoing challenges America faces in tackling excessive alcohol consumption, revealing a historical pattern of neglect.
Latest Medicine stories from Life.
STAT highlights the ongoing challenges America faces in tackling excessive alcohol consumption, revealing a historical pattern of neglect.
Pharmaceutical companies have ramped up their lobbying efforts, spending over $130 million in 2025, while Bristol-Myers Squibb has announced a new partnership with a Chinese firm.
The gene therapy community expresses concern over the lack of information from Capsida regarding the brain receptor involved in a recent fatal incident.
Researchers are investigating how generative AI could potentially decrease the reliance on animal experiments in drug development, addressing ethical concerns.
The emotional toll of losing a pet extends beyond humans, affecting surviving animals as well. This piece reflects on the grief experienced by both parties.
Recent reports indicate that significantly fewer seniors are utilizing expensive Alzheimer's medications than initially anticipated by Medicare.
Recent developments in biotech include Astellas' promising treatment for rare diseases, amid challenges in Alzheimer's drug rollout and insights from a China-based heart drug startup.
Following a challenging period marked by both remarkable recoveries and tragic losses, Astellas is revisiting its gene therapy approach for XLMTM, offering renewed hope to affected families.
In a recent discussion, Dr. Glaucomflecken highlights the necessity of maintaining local medical practices to better serve patients and communities, urging for national attention on the issue.
A new sensor, comparable in size to a grain of rice, promises to significantly improve the functionality of robots and medical devices by measuring forces and twisting motions using light.
Capricor Therapeutics has raised concerns about Nippon Shinyaku and its U.S. branch regarding the implementation of a treatment for Duchenne muscular dystrophy.
Recent findings highlight the potential of nanoparticles in fighting drug-resistant cancer, offering new hope for improving chemotherapy outcomes through advanced treatment methods.
Today's biotech news highlights a lawsuit concerning Duchenne therapy and challenges faced by FDA Commissioner Marty Makary in relation to the White House.
This brief outlines the GENEROUS model and explores various elements that may influence Medicaid drug costs, emphasizing the importance of confidentiality regarding certain model details.
A recent study indicates that lubiprostone, a medication typically used for constipation, may play a role in slowing the progression of chronic kidney disease in patients.
Energy Fuels is positioning itself as a key player in the nuclear energy sector with a diverse portfolio that includes uranium, rare earth elements, and medical isotopes.
Researchers from the University of Michigan and MD Anderson Cancer Center have developed a novel nanoparticle therapy that may enhance cancer immunotherapy's safety and efficacy.
Recent developments suggest that a political appointee may be obstructing the approval process for a Sanofi drug, raising alarms about potential political interference at the FDA.
Sanofi has requested the FDA to withdraw teplizumab from its fast-track review program following internal disagreements regarding the drug's approval.
Following a surprising rejection, the FDA will revisit the treatment for a rare cancer, as the developers of Ebvallo have reached an agreement to tackle the concerns raised.